Cardiology

  • 2019 Update in perioperative cardiovascular medicine
    Steven L. Cohn, MD, MACP, SFHM, Paul J. Grant, MD, SFHM, FACP and Barbara Slawski, MD, MS, SFHM
    Cleveland Clinic Journal of Medicine October 2019, 86 (10) 677-683; DOI: https://doi.org/10.3949/ccjm.86a.19077

    Studies of preoperative cardiac risk assessment, perioperative medication management, and postoperative complications.

  • Cardiovascular complications of systemic sclerosis: What to look for
    Cardiovascular complications of systemic sclerosis: What to look for
    Preethi Mani, MD, Danny Gonzalez, MD, Soumya Chatterjee, MD, MS, FRCP and Michael D. Faulx, MD
    Cleveland Clinic Journal of Medicine October 2019, 86 (10) 685-695; DOI: https://doi.org/10.3949/ccjm.86a.18109

    Pulmonary arterial hypertension, atherosclerosis, heart failure, arrhythmias, pericardial disease, and valvular heart disease.

  • Clinical outcomes in diabetes: It’s not just the glucose (and it’s not so simple)
    Brian F. Mandell, MD, PhD
    Cleveland Clinic Journal of Medicine September 2019, 86 (9) 573-574; DOI: https://doi.org/10.3949/ccjm.86b.09019

    As we dig deeper into the reduction in cardiovascular deaths seen with some newer drugs, several questions arise.

  • A young man with acute chest pain
    Amir Farid, MD, Neil Beri, MD, David Torres-Barba, MD, PhD and Charles Whitcomb, MD
    Cleveland Clinic Journal of Medicine September 2019, 86 (9) 586-594; DOI: https://doi.org/10.3949/ccjm.86a.19025

    A young man presents with severe, pressure-like, midsternal, nonradiating pain, rated 10 on a scale of 10.

  • ACE inhibitors and ARBs: Managing potassium and renal function
    Tasnim Momoniat, MBCHB, MRCP (UK), Duha Ilyas, MBBS, MRCP (UK) and Sunil Bhandari, MBCHB, FRCP, PhD, M CLIN EDU, FHEA
    Cleveland Clinic Journal of Medicine September 2019, 86 (9) 601-607; DOI: https://doi.org/10.3949/ccjm.86a.18024

    Concern about hyperkalemia and a decline in renal function has led to underuse of these drugs.

  • ACE inhibitor and ARB therapy: Practical recommendations
    Hernan Rincon-Choles, MD, MS
    Cleveland Clinic Journal of Medicine September 2019, 86 (9) 608-611; DOI: https://doi.org/10.3949/ccjm.86a.19016

    Inhibitors of the renin-angiotensin-aldosterone system are cornerstones of therapy of cardiovascular disease.

  • Disparities in cardiovascular care: Past, present, and solutions
    Quentin R. Youmans, MD, Lindsey Hastings-Spaine, MD, Oluseyi Princewill, MD, MPH, Titilayo Shobayo, BS and Ike S. Okwuosa, MD
    Cleveland Clinic Journal of Medicine September 2019, 86 (9) 621-632; DOI: https://doi.org/10.3949/ccjm.86a.18088

    Cardiovascular disease makes no distinction in race, sex, age, or socioeconomic status, and neither should clinicians.

  • Deciding when a picture is worth a thousand words and several thousand dollars
    Brian F. Mandell, MD, PhD
    Cleveland Clinic Journal of Medicine August 2019, 86 (8) 509-510; DOI: https://doi.org/10.3949/ccjm.86b.08019

    Physical examination is cheap but not highly reproducible. Imaging is expensive but may be more sensitive and specific.

  • Should we stop aspirin before noncardiac surgery?
    Anbazhagan Prabhakaran, MD, MRCP (Edin), FACP and Christopher Whinney, MD, SFHM, FACP
    Cleveland Clinic Journal of Medicine August 2019, 86 (8) 518-521; DOI: https://doi.org/10.3949/ccjm.86a.18075

    It depends on the type of surgery and the reason the patient is taking aspirin.

  • Aspirin: 4,000 years and still learning
    Kenneth C. Cummings, MD, MS, FASA
    Cleveland Clinic Journal of Medicine August 2019, 86 (8) 522-524; DOI: https://doi.org/10.3949/ccjm.86a.19041

    What we know about aspirin—and what we still need to learn.

Pages